163 related articles for article (PubMed ID: 12074629)
1. Modulation of microvascular signaling by heparan sulfate matrix: studies in syndecan-4 transgenic mice.
Li J; Partovian C; Li J; Hampton TG; Metais C; Tkachenko E; Sellke FW; Simons M
Microvasc Res; 2002 Jul; 64(1):38-46. PubMed ID: 12074629
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo.
Zhang Y; Li J; Partovian C; Sellke FW; Simons M
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2078-82. PubMed ID: 12543640
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
4. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
Voisine P; Li J; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Rosinberg A; Malik T; Nakai Y; Sellke FW
Circulation; 2005 Aug; 112(9 Suppl):I202-7. PubMed ID: 16159817
[TBL] [Abstract][Full Text] [Related]
5. PR-39 coordinates changes in vascular smooth muscle cell adhesive strength and locomotion by modulating cell surface heparan sulfate-matrix interactions.
Chon JH; Houston MM; Xu C; Chaikof EL
J Cell Physiol; 2001 Nov; 189(2):133-43. PubMed ID: 11598898
[TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor regulates expression of heparan sulfate in human periodontal ligament cells.
Shimabukuro Y; Ichikawa T; Terashima Y; Iwayama T; Oohara H; Kajikawa T; Kobayashi R; Terashima H; Takedachi M; Terakura M; Hashikawa T; Yamada S; Murakami S
Matrix Biol; 2008 Apr; 27(3):232-41. PubMed ID: 18036796
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
8. Developmental and cell-type-specific expression of cell surface heparan sulfate proteoglycans in the rat heart.
Asundi VK; Keister BF; Stahl RC; Carey DJ
Exp Cell Res; 1997 Jan; 230(1):145-53. PubMed ID: 9013716
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts.
Egi K; Conrad NE; Kwan J; Schulze C; Schulz R; Wildhirt SM
Eur J Cardiothorac Surg; 2004 Aug; 26(2):262-9. PubMed ID: 15296881
[TBL] [Abstract][Full Text] [Related]
10. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
13. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo.
Scotland RS; Madhani M; Chauhan S; Moncada S; Andresen J; Nilsson H; Hobbs AJ; Ahluwalia A
Circulation; 2005 Feb; 111(6):796-803. PubMed ID: 15699263
[TBL] [Abstract][Full Text] [Related]
14. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
15. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
16. Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.
Quaschning T; Voss F; Relle K; Kalk P; Vignon-Zellweger N; Pfab T; Bauer C; Theilig F; Bachmann S; Kraemer-Guth A; Wanner C; Theuring F; Galle J; Hocher B
J Am Soc Nephrol; 2007 Mar; 18(3):730-40. PubMed ID: 17287431
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
19. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells.
Li Y; Zheng J; Bird IM; Magness RR
Endothelium; 2005; 12(1-2):21-39. PubMed ID: 16036314
[TBL] [Abstract][Full Text] [Related]
20. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
